Marine Compounds and Cancer: Updates 2020

Sergey A Dyshlovoy; Friedemann Honecker

doi:10.3390/md18120643

Marine Compounds and Cancer: Updates 2020

Mar Drugs. 2020 Dec 15;18(12):643. doi: 10.3390/md18120643.

Authors

Sergey A Dyshlovoy^{1

2

3}, Friedemann Honecker^{2

4}

Affiliations

¹ Laboratory of Pharmacology, A.V. Zhirmunsky National Scientific Center of Marine Biology, Far Eastern Branch, Russian Academy of Sciences, 690041 Vladivostok, Russia.
² Laboratory of Experimental Oncology, Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, Hubertus Wald-Tumorzentrum, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.
³ Martini-Klinik, Prostate Cancer Center, University Hospital Hamburg-Eppendorf, 20251 Hamburg, Germany.
⁴ Tumor and Breast Center ZeTuP St. Gallen, 9000 St. Gallen, Switzerland.

Abstract

By the end of the year 2020, there are nine marine-derived anticancer drugs available on the market, and the field is currently growing exponentially [...].

Publication types

Editorial

MeSH terms

Animals
Antineoplastic Agents / pharmacology
Antineoplastic Agents / therapeutic use*
Biological Products
Humans
Marine Biology*
Marine Toxins / pharmacology
Marine Toxins / therapeutic use*
Neoplasms / drug therapy*

Substances

Antineoplastic Agents
Biological Products
Marine Toxins